[Use of elipten in Itsenko-Cushing disease (preliminary report)].
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D015068:17-Ketosteroids / Q000097:blood / Q000652:urine; D000293:Adolescent; D000311:Adrenal Glands / Q000503:physiopathology*; D000328:Adult; D000616:Aminoglutethimide / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D011728:Pyridones / Q000627:therapeutic use*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000814:Aniline Compounds; D000927:Anticonvulsants; D011728:Pyridones; D000616:Aminoglutethimide
Primenenie éliptena pri bolezni Itsenko-Kushinga (preduaritel'noe soobshchenie.